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ABSTRACT 
Objective: A new spectrophotometric method for the determination of propranolol hydrochloride (PRO) and metoprolol tartrate (MTP), beta 
blocker drugs, has been developed for their analysis in pharmaceutical dosage forms for the purpose of quality control and water samples for 
monitoring impact on environmental water quality of natural sources and in biological fluids for ascertaining their physiological performance. 
Methods: The method is based on the derivatization of the amino function present in these drugs to the corresponding yellow copper (I) drug 
dithiocarbamate derivative through reaction with carbon disulphide, pyridine and copper (I) perchlorate in aqueous acetonitrile and measuring 
absorbance at 406 nm for propranolol and 400 nm for metoprolol. The different experimental parameters affecting the development and stability of 
the colour were carefully studied and optimized. 
Results: The Beer’s law is obeyed in the range of 1.0-40.0 μg/ml of each drug solution with a correlation coefficient 0.999. The maximum relative 
standard deviations (RSDs) in the analysis of pure PRO and MTP were 1.01 and 1.52 % respectively. The recoveries of the drugs from 
pharmaceutical formulations, spiked water samples and biological fluids were in the range 98.0-100.5 % with RSDs in the range 0.23-1.94% 
indicating good accuracy and precision of the method.  
Conclusion: The instantaneous development of colour and its stability, well-established stoichiometry of the reaction and above simplicity and 
rapidity of procedures are some special attributes of the proposed method.  
Keywords: Propranolol hydrochloride, Metoprolol tartrate, Spectrophotometric method, Spiked water samples, Simulated biological fluids. 




Propranolol hydrochloride (PRO), 1-[isopropylamino-3-[1-
naphthyloxy]-2-propanol hydrochloride (fig. 1 A), and metoprolol 
tartrate (MTP), 1-(isopropylamino)-3-[p-(2-methoxyethyl) phenoxy] 
-2-propanol tartrate (fig. 1 B), are β-blocker drugs commonly used 
to treat several diseases such as hypertension, myocardial infarction, 
arrhythmias, angina pectoris and hyperthyroidism [1-4]. These 
drugs are also sometimes used as a doping agent in sports, but 
because of their sedative effects these are now listed as forbidden 
drugs [5-6]. PRO became the best-selling drug for treatment of a 
wide range of cardiovascular diseases. The progress in β-blocker 
drug development led to the introduction of MTP because of its 
relative selectivity for cardiac β1-receptors. The pharmaceutical 
industry has the responsibility of supplying drugs in the purest 
forms to satisfy the medical profession and public demand. In the 
same context in order to maintain uniform therapeutic standards 
with respect to both dosage form and quality, it is highly desirable 
that the quality of the various dosage forms of these drugs being 
marketed be ensured. The beneficial effects of a drug are maximized 
when the plasmatic concentration remains in its therapeutic range. 
Therapeutic drug monitoring is a clinical practice, carried out 
through the quantification of the drug and its main metabolites in 
physiological fluids at several times after the ingestion of the 
pharmaceutical formulation [7]. β-blockers have also been found in 
the water affecting its quality characteristics when people excrete 
them and simply flush out the outdated and unused drugs and are 
now considered as water pollutants [8-9].  
Owing to the therapeutical, pharmacological and environmental 
relevance of PRO and MTP their rapid and accurate determination in 
commercial formulations, biological fluids and water samples is of 
great importance. Several methods have been reported for the 
determination of these drugs which includes spectrophotometry 
[10-12], spectrofluorimetry [13-14], gas chromatography-mass 
spectrometry (GC-MS) [15-16], high-performance liquid 
chromatography (HPLC) [17-18], liquid chromatography-mass 
spectrometry (LC-MS) [19-21], chemiluminescence [22-23], 
capillary electrophoresis [24-25] and voltammetry [26-27]. 
Spectrophotometric methods because of their inherent simplicity 
and rapidity of the procedure and low cost of the techniques find 
favour in most laboratories of limited means and consequently these 
methods continue to flourish. 
 
 
Fig. 1: Chemical structure of (A) PRO and (B) MTP 
 
In our efforts to develop a spectrophotometric method for the 
determination of listed drugs, the reaction of their secondary amino 
function with carbon disulphide and copper (I) perchlorate in 
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aqueous acetonitrile media in the presence of pyridine to form an 
intense yellow coloured copper (I)-drug dithiocarbamate complex is 
investigated. The analysis is accomplished by measuring the 
intensity of the yellow colour at 406 nm for PRO and 400 nm for 
MTP by direct colorimetric or photometric titrimetric procedures. 
The latter procedure is rapid and precise as no calibration graph is 
required to be prepared, but the former is more sensitive. 
Optimizations of various experimental parameters, stoichiometry 
and proposed mechanism of colour reaction are also studied in 
developing the method for its application to the analysis of these 
drugs in pharmaceutical formulation, water samples and biological 
fluids. In the latter context simulated biological fluids (blood plasma, 
urine and phosphate buffer saline) artificially prepared were used. 
MATERIALS AND METHODS 
Apparatus  
All the absorbance measurements have been carried out using 
Varian-Cary 100 Bio UV-Visible Spectrophotometer and Bosch and 
Lomb spectrophotometer (spectronic 20 D+) with one cm matched 
glass cells. Microwave oven, (Samsung make) was used for carrying 
out hydrolysis and other reactions. Sonicator (Ultrasonic cleaner UC-
1202D) and centrifuge (Sigma laborzentrifugen 3K-30) were used 
during the investigations. 
Reagents and solutions 
The analytical standards of high purity of PRO (99 %) and MTP (98 
%) were procured from Sigma Aldrich, Bangalore, India. Double 
distilled water was used throughout. A stock standard solution of 
PRO and MTP was prepared by dissolving 10 mg of pure drug 
compound in 100 ml of double distilled water for obtaining a 
working concentration of 100 µg/ml drug solution. Copper (I) 
perchlorate and its standard solution (0.001 mol/l) was prepared by 
dissolving more than the calculated amount in acetonitrile and 
standardized by titrating it against standard ammonium 
hexanitrocerate (IV) solution using ferroin as an indicator [28]. 
Carbon disulphide (Merck, AR), pyridine (Merck, GS) and ethyl 
acetate (Merck, AR) were used as received. Commercial chloroform 
was purified by allowing it to stand over anhydrous potassium 
carbonate (AR) overnight and then distilled. The fractional distilling 
at 55 °C was collected. 
Simulated biological fluids 
The simulated blood plasma, urine and phosphate buffer saline used 
for the determination of PRO and MTP are prepared as proposed by 
Kokubo et al. [29], Miller et al. [30] and Singh et al. [31] respectively. 
Standard procedure 
Aliquots (0.1-2.0 ml) of the standard drug solutions (100 µg/ml) of 
PRO and MTP were taken in 5 ml-measuring flasks and volume made 
to 2 ml with water. Each solution was mixed with 1 ml of pyridine 
and one drop (~ 50 µl) of carbon disulphide and the contents were 
kept in a microwave for 40 s for the completion of the reaction. Each 
solution was then mixed with copper (I) perchlorate (1 ml, 0.001 
mol/lin acetonitrile) and volume made up to the mark with 
acetonitrile. The yellow colour which developed immediately was 
measured at 406 nm for propranolol and 400 nm for metoprolol 
against a reagent blank. Calibration graphs were constructed for 
each drug compound by plotting absorbance corresponding to 
different concentrations of the drug.  
Photometric titration procedure 
Aliquots of standard solutions (0.0002 mol/l) of PRO and MTP in 
distilled water were taken in colourimetric tubes and the volume 
made to 2 ml with water. Each solution, then mixed with 1 ml of 
pyridine and 1 drop of carbon disulphide and kept in the microwave 
for 40 s. Each solution was then titrated photometrically at room 
temperature (~ 24 °C) with standard copper (I) perchlorate (0.0002 
mol/l) by adding reagent in small instalments, stirring the solution 
magnetically (with a specially designed stirring disk) each time and 
measuring the absorbance at their respective wavelengths i.e. 406 
nm for PRO and 400 nm for MTP against a reagent blank. 
Absorbance values were corrected to the initial volume of the 
solution by multiplying the absorbance readings by a factor V+v/V, 
where V is the initial volume and v is the volume of standard copper 
(I) perchlorate added for a particular absorbance reading being 
measured. A plot of absorbance versus ml of titrant was then made 
and the best straight line drawn between the points taken well 
before and after the equivalence point. An inverted L-shaped 
titration curve was obtained in each case and the intersection of 
linear segments was taken as the end point. 
Procedure for the assay of PRO and MTP in pharmaceutical 
formulations 
The following pharmaceutical formulations of these drugs were 
purchased from local authorized dealers: Inderal-40 (Abbott 
Healthcare Pvt. Ltd. Himachal Pradesh, India) labelled to contain 40 
mg of PRO, Ciplar-10 (Cipla Ltd. Sikkim, India) labelled to contain 50 
mg of PRO per tablet and Metolar-50 and Metolar-25 (Cipla Ltd. Goa, 
India) labelled to contain respectively 50 and 25 mg of MTP per tablet. 
A known number of tablets (20 tablets) of each drug formulation were 
weighed and crushed into powder. A stock solution was prepared by 
dissolving accurately weighed amount equivalent to 10 mg of active 
ingredient in distilled water and sonicated for 10 min. The solution 
was filtered and the residue was washed 2-3 times with distilled 
water. The filtrate and washings were diluted to 100 ml with distilled 
water. Suitable aliquots of the drug extracts were taken for analysis as 
described above for pure drug compounds, both by colorimetric as 
well as photometric titration procedures. 
Procedure for the assay of PRO and MTP in spiked water 
samples 
Tap water (10 ml) taken in different flasks were mixed with various 
aliquots of the standard solution (100 µg/ml) of each drug. Each 
solution was mixed with 1 ml of pyridine and one drop (~ 50 µl) of 
carbon disulphide. The contents were kept in a microwave for 40 s 
for the completion of the reaction. Each solution was then mixed 
with copper (I) perchlorate (1 ml, 0.001 mol/l in acetonitrile). The 
yellow coloured solution was equilibrated with 5 ml of chloroform 
for 5 min. The yellow chloroform layer was separated and dried by 
shaking with anhydrous sodium sulphate (2 g) and the absorbance 
of the resulting yellow colour was measured at 418 nm and 414 nm 
respectively for PRO and MTP. The calibration graphs were 
constructed by plotting absorbance against concentration of the 
drug in the usual way. The analysis of the drug is made by referring 
the observed absorbance values to calibration graph. PRO and MTP 
in the ranges 1.0-40.0 µg/ml can be determined by this procedure. 
Procedure for the assay of PRO and MTP in simulated body 
fluids 
Simulated biological fluids viz. blood plasma, urine and phosphate 
buffer saline (5 ml) taken in different 30 ml centrifuge tubes, were 
mixed with suitable aliquots of the standard (100 µg/ml) solution of 
each drug. Each solution was then mixed with 5 ml of 0.5 mol/l 
ammonium hydroxide solution and sonicated for 5 min. After 
sonication, 5 ml of ethyl acetate was added to each solution, shaken 
for 5 min and the contents were centrifuged for 10 min at 3000 rpm. 
The supernatant (ethyl acetate layer) was separated and the solvent 
was evaporated to dryness over a water bath. The residue was 
dissolved in 2 ml of distilled water and sonicated for 5 min and 
processed for analysis in the same manner as described above under 
standard procedure. 
RESULTS AND DISCUSSION 
Spectral characterization 
Based on the reaction of primary and secondary amines with carbon 
disulphide in the presence of a base to form dithiocarbamate 
complexes, spectrophotometric methods for the determination of 
amines and carbon disulphide have been developed in our 
laboratory [32-34]. The advantage of this approach has now been 
demonstrated in the present work in the analysis of PRO and MTP 
drugs. The instantaneous development of colour, well-established 
stoichiometry of the colour reaction, the stability of colour and 
reagent solutions are some of the salient features of the proposed 
method. It possesses advantages over the existing spectro-
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photometric methods in terms of simplicity and rapidity of the 
procedures and sensitivity of the method (table 1). 
In the proposed method the amino function of each drug is 
transformed into corresponding copper (I) drug dithiocarbamate 
complexes through reaction with carbon disulphide, copper (I) 
perchlorate in the presence of pyridine. The colour is measured at 
406 and 400 nm respectively. The absorption spectra of copper (I) 
drug dithiocarbamates are shown in fig. 2. The plausible reaction 
mechanism is depicted in fig. 3. 
  
Table 1: Comparison of the proposed method with the existing spectrophotometric methods for the determination of PRO and MTP 
Reagents Linearity range (µg/ml) Reaction time Reference 
PRO MTP 
Iodine 6-36 6-36 5 min [8] 
Chloranil 4-24 4-24 5 min [8] 
Bromanil 20-120 20-120 20 min [8] 
4-chloro-7-nitro-2,1,3-benzoxadiazole -- 0.8-60 10 min [9] 
1-chloro-2,4-dinitrobenzene 4-16 -- 30 min [10] 
Carbon disulphide-pyridine-Copper(I) perchlorate 1-40 1-40 40 s Proposed method 
PRO: propranolol hydrochloride, MTP: metoprolol tartrate. 
 
 
Fig. 2: Absorption spectra of PRO and MTP as copper (I) drug dithiocarbamate complex 
 
 
Fig. 3: Plausible reaction mechanism for the proposed method 
 
During the course of the investigation, it was observed that the 
development of colour and its stability was less; colour intensity 
attained stable values after 15 min. To overcome these problems the 
colour reactions forming the basis of proposed methods were 
carried out in a microwave oven. The microwave assisted reactions 
to accelerate the reaction rate and is an effective alternative to the 
conventional procedure as there is no loss of analyte and the 
contamination of atmosphere [35]. 
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Optimization of reaction conditions 
The various reaction conditions of PRO and MTP in pure and 
pharmaceutical formulations assay were carefully studied and 
optimised. The parameters optimized include heating time, the effect 
of reagent volume, the effect of extracting solvents and stability of 
colour. 
Effect of heating time 
The heating time in a microwave was varied from 10-80 s to obtain 
maximum colour intensity and stability. The best results were 
obtained corresponding to 40 s of heating (fig. 4). Reaction time less 
than 40 s gave less colour intensity. 
 
 
Fig. 4: Effect of heating time 
 
Effect of reagent volume and solvent 
The various volumes of a particular concentration of carbon 
disulphide, pyridine and copper (I) perchlorate were studied at a 
fixed concentration of the drug and their effects on the colour 
development and its intensity was investigated. It was found that the 
reproducible results with highest colour intensity were obtained 
with 1 drop (~50 µl) of carbon disulphide, 1 ml of pyridine and 1 ml 
of 0.001 mol/l copper (I) perchlorate. The excess addition of 
reagents causes a decrease in the colour intensity.  
Effect of extracting solvents 
Of the three extracting solvents viz. chloroform, methyl isobutyl 
ketone (MIBK) and ethyl acetate for the extraction of the yellow 
copper (I) drug dithiocarbamate complex in the analysis of drugs 
from spiked water samples, chloroform has been selected because it 
extracts the complex almost completely and the extract show 
highest colour intensity and stability.  
With regards to the assay of these drugs from simulated biological 
fluids, ethyl acetate has been found excellent giving higher 
recoveries of drugs. 
Stoichiometric ratio 
The stoichiometry of drug as its dithiocarbamate derivative and 
copper (I) reaction has been established by photometric titrations 
which in fact is the Job’s method of continuous variation. In 
photometric titrations of each drug (as respective dithiocarbamate 
derivative) against copper (I) perchlorate at respective wavelengths, 
absorbance increases till 1:1 (1:2 for MTP) drug-copper reagent 
molar ratio indicating the formation of yellow copper (I) drug 
dithiocarbamate complex and thereafter it attains constant values 
thus establishing the above stoichiometry (fig. 5 and 6). 
  
 
Fig. 5: Photometric titration curve of PRO with copper (I) perchlorate 




Fig. 6: Photometric titration curve of MTP with copper (I) perchlorate 
 
Validation of proposed method 
The following validation parameters were tested according to the 
guidelines set by the international conference on harmonization 
(ICH) [36]: linearity, accuracy, precision, limit of detection (LOD) 
and the limit of quantitation (LOQ). 
Linearity 
Under the optimized conditions, the linearity between absorbance and 
concentration (calibration graph) were in the range 1.0-40.0 µg ml for 
each drug compound (fig. 7). The linearity of calibration graphs was 
proved by the high values of the correlation coefficient (r) and the 
small values of the y-intercepts of the regression equations. 
Y = mX + C 
(Where Y= Absorbance, m= slope, C= intercept and X= concentration 
in μg/ml). 
The various optical and calibration parameters viz. Beer’s law range, 
Sandell’s sensitivity, molar absorptivity, slope and intercept values 
for each drug compound have been calculated and are summarized 
in table 2. 
  
 
Fig. 7: Calibration graph of PRO and MTP as copper (I) drug dithiocarbamate complex 
 
Table 2: Optical characteristics and statistical data of the regression line 
Characteristics PRO  MTP  
λmax (nm) 406 400 
Beer’s law range (µg/ml) 1.00-40.00 1.00-40.00 
Molar absorptivity (ε, l mol-1 cm-1) 3.668x103 1.736x104 
Stability (min.) 60 60 
Slope 0.0114 0.0211 
Intercept 0.0185 0.0626 
Correlation coefficient (r) 0.999 0.999 
Sandell’s sensitivity (µg/cm2) 8.06x10-2 3.94x10-2 
Limit of detection (µg/ml) 0.28 0.18 
Limit of quantification (µg/ml) 0.87 0.56 
PRO: propranolol hydrochloride, MTP: metoprolol tartrate. 
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Limit of detection and quantification 
The limits of detection (LOD) and quantification (LOQ) have been 
determined by ICH guidelines [36] using the following equation and 
also listed in table 2. 
LOD = 3.3 σ/s 
And 
LOQ = 10 σ/s 
Where σ is the standard deviation of the intercept of the regression 
line and s is the slope of the calibration curve.  
Accuracy and precision 
The accuracy and precision of the proposed method were evaluated 
by performing five replicate analyses of pure drug solutions at five 
different concentration levels over the ranges 2.0-40.0 µg/ml with a 
maximum relative standard deviation (RSD) of 1.01 and 1.52 % 
respectively for PRO and MTP (table 3). Though photometric 
titrations of each drug compound as dithiocarbamate derivative 
with copper (I) perchlorate helped us in establishing the 
stoichiometry of the colour reaction, but have also afforded another 
method for the analysis of these drugs. PRO and MTP in the ranges 
2.4-21.3 µg/ml and 2.7-24.6 µg/ml have been determined by a 
photometric titration method with maximum RSDs of 0.84 and 0.80 
% (table 4). The results obtained with both the procedures, i.e. 
colourimetric as well as photometric titrimetric were in good 
agreement with those obtained using the comparison method [11]. 
The low values of the relative standard deviation (<2.0 %) in all 
cases show the good precision of the proposed method. The 
accuracy and reliability of the proposed assay are confirmed by 
applying the Student's t-test. 
 
Table 3: Application of the proposed method to the determination of studied drugs in pure forms: standard procedure 
Drugs Amount taken (µg/ml) Amount founda±SD (µg/ml) RE (%) RSD (%) 
PRO  2.0 2.01±0.02 0.50 0.99 
10.0 9.94±0.10 0.60 1.01 
 20.0 19.88±0.16 0.60 0.80 
 30.0 30.06±0.14 0.20 0.46 
 40.0 39.94±0.19 0.15 0.48 
MTP  2.0 1.98±0.03 1.00 1.52 
10.0 9.92±0.08 0.80 0.80 
 20.0 19.86±0.21 0.70 0.81 
 30.0 29.88±0.18 0.40 0.60 
 40.0 39.82±0.19 0.45 0.48 
SD: standard deviation, RE: relative error, RSD: relative standard deviation, PRO: propranolol hydrochloride and MTP: metoprolol tartrate, aValues 
expressed as mean±SD (n=5). 
 
Table 4: Application of the proposed method to the determination of studied drugs in pure forms: photometric titration procedure 
Drugs Amount taken (µg/ml) Amount founda±SD (µg/ml) RE (%) RSD (%) 
PRO  2.4 2.38±0.02 0.83 0.84 
7.1 7.08±0.05 0.28 0.71 
 11.8 11.73±0.09 0.59 0.77 
 16.6 16.62±0.07 0.12 0.42 
 21.3 21.18±0.14 0.56 0.66 
MTP  2.7 2.71±0.02 0.37 0.74 
8.2 8.16±0.06 0.49 0.73 
 13.7 13.74±0.11 0.29 0.80 
 19.2 18.98±0.14 0.63 0.74 
 24.6 24.46±0.19 0.57 0.78 
SD: standard deviation, RE: relative error, RSD: relative standard deviation, PRO: propranolol hydrochloride and MTP: metoprolol tartrate, aValues 
expressed as mean±SD (n=5) 
 
Interference 
Under the optimized experimental conditions, common excipients 
such as starch, talc, magnesium stearate and lactose did not interfere 
in the proposed method. The high percent recoveries of the active 
ingredients from commercial drug formulations further support the 
above observation (table 5 and 6). 
Assay of pharmaceutical formulations 
The results have been compared with an independent method [11]. 
The results of the determination of PRO and MTP from commercial 
pharmaceutical formulations are in good accordance with maker’s 
specification.
 






























Inderal-40 40 mg per 
tablet 
4.0 3.97±0.05 99.25 1.26 1.34 4.7 4.70±0.04 99.37 0.85 1.68 
8.0 7.92±0.13 99.00 1.64 1.38 9.5 9.38±0.09 99.15 0.96 1.99 
16.0 15.85±0.19 99.06 1.19 1.76 14.2 14.25±0.13 100.35 0.91 0.86 
32.0 32.13±0.21 100.41 0.65 1.38 18.9 18.87±0.07 99.68 0.37 1.92 
Ciplar-10 10 mg per 
tablet 
4.0 3.95±0.06 98.75 1.52 1.86 4.7 4.69±0.04 99.15 0.85 2.24 
8.0 8.06±0.15 100.75 1.86 0.89 9.5 9.48±0.08 100.21 0.84 0.56 
16.0 15.88±0.14 99.25 0.88 1.92 14.2 14.09±0.14 99.22 0.99 1.76 
32.0 31.92±0.20 99.75 0.63 0.89 18.9 18.87±0.07 99.68 0.37 1.92 
SD: standard deviation, RSD: relative standard deviation, aMaker’s specifications established by an independent method [11], bValues expressed as 
mean±SD (n=5), cTheoretical t-value at 95% confidence level is 2.776 
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Metolar-50 50 mg per 
tablet 
4.0 4.02±0.07 100.50 1.74 0.64 5.5 5.49±0.03 99.82 0.55 0.74 
8.0 7.89±0.15 98.62 1.90 1.64 11 10.90±0.10 99.09 0.92 1.96 
16.0 16.07±0.09 100.44 0.56 1.74 16.4 16.32±0.16 99.51 0.98 1.67 
32.0 32.04±0.19 100.12 0.59 0.47 21.9 21.78±0.18 99.45 0.83 1.61 
Metolar-25 25 mg per 
tablet 
4.0 3.98±0.03 99.50 0.75 1.49 5.5 5.52±0.03 100.36 0.54 2.23 
8.0 8.03±0.12 100.37 1.49 0.56 11 10.93±0.10 99.36 0.91 2.01 
16.0 15.93±0.17 99.56 1.07 0.92 16.4 16.28±0.15 99.27 0.92 2.38 
32.0 31.90±0.20 99.69 0.63 1.12 21.9 21.76±0.19 99.36 0.87 1.76 
SD: standard deviation, RSD: relative standard deviation, aMaker’s specifications established by an independent method [11], bValues expressed as 
mean±SD (n=5), cTheoretical t-value at 95% confidence level is 2.776 
 
Table 7: Application of the proposed method to the determination of PRO and MTP in spiked water samples 
Drug Amount taken (µg) Amount founda (µg) Recovery (%) RSD (%) 
PRO 10.0 9.95±0.08 99.50 0.80 
20.0 19.89±0.13 99.45 0.65 
30.0 29.76±0.24 99.20 0.81 
MTP 10.0 9.97±0.07 99.70 0.70 
20.0 19.83±0.17 99.15 0.86 
30.0 29.74±0.25 99.13 0.84 
RSD: relative standard deviation, PRO: propranolol hydrochloride and MTP: metoprolol tartrate, aValues expressed as mean±SD (n=5) 
 
Table 8: Application of the proposed method to the determination of PRO and MTP in simulated blood plasma 
Drug Amount taken (µg) Amount founda (µg) Recovery (%) RSD (%) 
PRO 10.0 9.80±0.19 98.00 1.94 
20.0 19.84±0.17 99.20 0.86 
30.0 29.75±0.25 99.17 0.84 
MTP 10.0 9.92±0.09 99.20 0.91 
20.0 19.93±0.12 99.65 0.60 
30.0 29.87±0.15 99.57 0.50 
RSD: relative standard deviation, PRO: propranolol hydrochloride and MTP: metoprolol tartrate, aValues expressed as mean±SD (n=5). 
 
Table 9: Application of the proposed method to the determination of PRO and MTP in simulated urine 
Drug Amount taken (µg) Amount founda (µg) Recovery (%) RSD (%) 
PRO 10.0 9.97±0.09 99.70 0.90 
20.0 19.91±0.18 99.55 0.90 
30.0 30.04±0.07 100.13 0.23 
MTP 10.0 9.92±0.11 99.20 1.11 
20.0 19.88±0.19 99.40 0.96 
30.0 29.91±0.23 99.70 0.77 
RSD: relative standard deviation, PRO: propranolol hydrochloride and MTP: metoprolol tartrate, aValues expressed as mean±SD (n=5). 
 
Table 10: Application of the proposed method to the determination of PRO and MTP in phosphate buffer saline 
Drug Amount taken (µg) Amount founda (µg) Recovery (%) RSD (%) 
PRO 10.0 9.90±0.18 99.00 1.82 
20.0 19.88±0.21 99.40 1.06 
30.0 30.04±0.24 100.13 0.80 
MTP 10.0 9.95±0.07 99.50 0.70 
20.0 19.76±0.24 98.80 1.21 
30.0 29.84±0.19 99.47 0.64 
RSD: relative standard deviation, PRO: propranolol hydrochloride and MTP: metoprolol tartrate, aValues expressed as mean±SD (n=5). 
 
Recovery from spiked water samples 
The method when applied to the assay of each drug compound from 
spiked water samples gave high recoveries and low RSDs values 
indicating good accuracy and precision of the method (table 7). 
Recovery from simulated biological fluids 
The method has also been successfully validated for the 
determination of PRO and MTP in simulated biological fluids viz. 
simulated blood plasma, simulated urine and phosphate buffer 
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saline. The recoveries were good, in the range 98.00-100.13 % with 
RSDs in the ranges 0.23-1.94 %. (table 8-10). 
CONCLUSION 
The proposed spectrophotometric method is simple, rapid and 
sensitive offering analysis of PRO and MTP drugs both by 
colorimetric as well as photometric titration procedures. The latter 
also supports the stoichiometries of the colour reactions forming the 
basis of proposed methods. The instantaneous development of 
colour and its stability and well established stoichiometry of the 
reaction are other salient of the methods. The high recoveries of 
drugs from their commercial pharmaceutical formulations, spiked 
water samples and simulated biological fluids indicate good 
accuracy and precision of the method and hence can be 
recommended for their above said routine analysis. 
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